Your session is about to expire
← Back to Search
Cystomanometer Device for Neurogenic Bladder
Study Summary
This trial will test a new device that monitors pressure for people with neurogenic bladders who use clean intermittent catheterization. The device is already accurate compared to the gold standard.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- N/AI have been diagnosed with a neurogenic bladder.
- Group 1: Neurogenic Bladder Patient
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the highest possible number of individuals engaging in this clinical experiment?
"Affirmative. Clinicaltrials.gov reports that, since its initial posting on November 19th 2019 and last edit on May 17th 2022, this medical trial is still open for recruitment. Presently the research team needs 50 participants from a single site to complete their study."
To whom is this clinical trial open for participation?
"The study is currently recruiting 50 individuals with neurogenic bladder aged 1-99. To qualify, applicants must have a confirmed diagnosis of neurogenic bladder."
Does this research include participants who are of age 20 and above?
"This research seeks participants who are between 1 and 99 years of age."
Are individuals currently being admitted to this experimental endeavor?
"According to the data available on clinicaltrials.gov, this clinical trial is still open for registration and enrolling participants. It was first listed in November 2019 and its most recent update occurred back in May 2022."
Share this study with friends
Copy Link
Messenger